Implementation of Digital CBT for Insomnia in First Episode Psychosis
Implementation of a Digital Cognitive Behavioural Therapy Intervention for Insomnia in First Episode Psychosis in the Context of Covid19: A Mixed Methods Study
1 other identifier
interventional
22
1 country
2
Brief Summary
This study uses mixed methods to investigate the implementation of digital cognitive behavioural therapy for insomnia (Sleepio) in a first episode of psychosis service (FEP). Interviews will be conducted with keyworker clinicians and service users to consider their expectations for digital sleep intervention. The rates of recruitment into the study, eligibility, completion of baseline measures, completion of the intervention sessions, attrition from the intervention and completion of follow up measures will be recorded. Interviews will be conducted with keyworker clinicians and service users to consider their experiences of digital sleep intervention. The primary outcome will be a logic model describing factors acting upon the implementation of Sleepio in this population. The investigators will provide signal data in relation to changes in insomnia severity, psychosis symptomatology, and general mental health.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable
Started Apr 2021
2 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
April 20, 2021
CompletedFirst Submitted
Initial submission to the registry
August 5, 2021
CompletedFirst Posted
Study publicly available on registry
September 20, 2021
CompletedPrimary Completion
Last participant's last visit for primary outcome
April 20, 2022
CompletedStudy Completion
Last participant's last visit for all outcomes
September 30, 2022
CompletedSeptember 20, 2021
September 1, 2021
1 year
August 5, 2021
September 17, 2021
Conditions
Keywords
Outcome Measures
Primary Outcomes (5)
Implementation data - rates of consenting
Rates of consenting and nonconsenting interested participants
Across study timeline (8 months), across 10 weeks for Sleepio specific measures
Implementation data - eligibility
Number of eligible vs. ineligible participants and reasons for ineligibility
8 months
Implementation data - completion of measures
Participant completion of measures assessment appointments and measures (ISI measure of insomnia severity, DASS-21 measure of mental wellbeing, R-GPTS measure of paranoia, SPEQ measure of hallucination, and Fear of Covid19). This outcome records whether or not these were completed by participants, whereas secondary outcomes 6-10 examine participant scores on these measures.
8 months
Implementation data - completion of intervention sessions
Measures attrition from intervention by recording how many sessions of intervention were completed by participant.
Across 10 weeks per participant
Qualitative data
Service user and clinician expectations and experiences of digital CBT-I intervention
Across study timeline (8 months), across 12 weeks for service users (pre and post intervention)
Secondary Outcomes (5)
Insomnia severity
10 weeks
Mental Wellbeing
10 weeks
Paranoia symptomatology
10 weeks
Hallucination symptomatology
10 weeks
Anxiety regarding Covid19
10 weeks
Study Arms (1)
Sleepio Intervention
EXPERIMENTALParticipants using the Sleepio application - access for 6 sessions, over 10 weeks
Interventions
Eligibility Criteria
You may qualify if:
- Service users under the care of Esteem First Episode Psychosis Service in NHS GGC
- Potentially affected by Insomnia Disorder (defined by Sleep Condition Indicator-02 score ≤2)
- Who have access to a device they can use Sleepio on (a computer device with Safari or Google Chrome browser, or an iPhone device).
You may not qualify if:
- Moderate to severe learning disability
- Acute Psychosis (recent crisis contact or hospitalisation)
- Incapacity to provide informed consent
- Insufficient English to access intervention
- Organic impairment
- No access to a device which can be used for Sleepio intervention.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- NHS Greater Glasgow and Clydelead
- University of Glasgowcollaborator
- Big Health Inc.collaborator
Study Sites (2)
Esteem North, NHS Greater Glasgow and Clyde
Glasgow, G213UW, United Kingdom
Esteem South and Clyde, NHS Greater Glasgow and Clyde
Glasgow, G53 7TU, United Kingdom
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Andrew Gumley
NHS Greater Glasgow and Clyde; University of Glasgow
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NA
- Masking
- NONE
- Masking Details
- Participation is not masked - any service users who would like to participate may do so and their keyworker will be notified as a mandatory condition of consent
- Purpose
- TREATMENT
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
August 5, 2021
First Posted
September 20, 2021
Study Start
April 20, 2021
Primary Completion
April 20, 2022
Study Completion
September 30, 2022
Last Updated
September 20, 2021
Record last verified: 2021-09
Data Sharing
- IPD Sharing
- Will not share